Remdesivir Usage Guide Policy to be shown within a few weeks WHO October 17, 6:06
Regarding the antiviral drug remdesivir, which has been specially approved in Japan as a treatment for the new coronavirus, the WHO = World Health Organization announced on the 16th that it will provide WHO guidance on its use within a few weeks.
WHO announced on the 15th the preliminary results of clinical trials on the new coronavirus conducted at 405 hospitals in 30 countries, of which remdesivir will improve inpatient mortality and shorten hospital stays. Regarding whether or not, "it seems that there was almost no effect or no effect at all."
WHO Executive Director Tedros reiterated the tentative results at a press conference on the 16th and expressed his intention to publish the final report in the near future.
Remdesivir has already been approved as a treatment for the new coronavirus in several countries, including Japan.
In this regard, Chief Scientist Swaminasan said, "Regulators in each country will decide whether to continue special approval based on the data of this clinical trial," and WHO will also use it. We have announced a policy to provide guidance within a few weeks.
WHO says that dexamethasone, a steroid used in cases of pneumonia at this stage, is the only treatment that is effective in critically ill patients with the new coronavirus, and that other antiviral drugs will continue to be used in the future. We are planning to proceed with clinical trials using.